JPWO2020150389A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020150389A5
JPWO2020150389A5 JP2021540435A JP2021540435A JPWO2020150389A5 JP WO2020150389 A5 JPWO2020150389 A5 JP WO2020150389A5 JP 2021540435 A JP2021540435 A JP 2021540435A JP 2021540435 A JP2021540435 A JP 2021540435A JP WO2020150389 A5 JPWO2020150389 A5 JP WO2020150389A5
Authority
JP
Japan
Prior art keywords
glca
rha
glc
rha2
glyc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517237A (ja
Publication date
Application filed filed Critical
Priority claimed from US16/743,806 external-priority patent/US11622974B2/en
Publication of JP2022517237A publication Critical patent/JP2022517237A/ja
Publication of JPWO2020150389A5 publication Critical patent/JPWO2020150389A5/ja
Pending legal-status Critical Current

Links

JP2021540435A 2019-01-18 2020-01-15 プレバイオティック組成物およびその使用 Pending JP2022517237A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962794452P 2019-01-18 2019-01-18
US62/794,452 2019-01-18
US201962869248P 2019-07-01 2019-07-01
US62/869,248 2019-07-01
US16/743,806 US11622974B2 (en) 2019-01-18 2020-01-15 Prebiotic composition and its use
US16/743,806 2020-01-15
PCT/US2020/013742 WO2020150389A2 (en) 2019-01-18 2020-01-15 Prebiotic composition and its use

Publications (2)

Publication Number Publication Date
JP2022517237A JP2022517237A (ja) 2022-03-07
JPWO2020150389A5 true JPWO2020150389A5 (es) 2023-01-25

Family

ID=69740527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540435A Pending JP2022517237A (ja) 2019-01-18 2020-01-15 プレバイオティック組成物およびその使用

Country Status (13)

Country Link
US (2) US11622974B2 (es)
EP (1) EP3911179A2 (es)
JP (1) JP2022517237A (es)
CN (1) CN113784630A (es)
AU (1) AU2020209834A1 (es)
BR (1) BR112021014094A2 (es)
CA (1) CA3126547A1 (es)
DE (1) DE20708726T1 (es)
ES (1) ES2884072T1 (es)
MX (1) MX2021008072A (es)
SG (1) SG11202107687VA (es)
TW (1) TW202106312A (es)
WO (1) WO2020150389A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US11732059B2 (en) 2020-07-17 2023-08-22 Cp Kelco U.S., Inc. Sphingan oligosaccharides
WO2022240224A1 (ko) * 2021-05-14 2022-11-17 한국식품연구원 젤란검을 유효성분으로 하는 장내 균총 개선용 조성물 및 이를 포함하는 대사성 질환 개선, 예방 또는 치료용 조성물

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326053A (en) 1978-12-04 1982-04-20 Merck & Co., Inc. Polysaccharide S-60 and bacterial fermentation process for its preparation
US4342866A (en) 1979-09-07 1982-08-03 Merck & Co., Inc. Heteropolysaccharide S-130
US4401760A (en) 1981-10-21 1983-08-30 Merck & Co., Inc. Heteropolysaccharide S-194
US5175278A (en) 1985-06-28 1992-12-29 Merck & Co., Inc. Heteropolysaccharide S-657
US5175277A (en) 1991-03-20 1992-12-29 Merck & Co., Inc. Rapidly hydrating welan gum
US5342626A (en) 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
MD992G2 (ro) 1996-03-15 1999-02-28 Государственный аграрный университет Молдовы Gură de ventilaţie a depozitului de păstrare a fructelor
CA2334635A1 (en) 1998-06-10 1999-12-16 Monsanto P.L.C. Modified gellan gum composition process for preparation of same and use thereof
US6242035B1 (en) 1998-11-23 2001-06-05 Cp Kelco U.S., Inc. Reduced molecular weight native gellan gum
US20110027838A1 (en) 2009-07-31 2011-02-03 Harding Nancy E Sphingomonas Strains Producing Greatly Increased Yield Of PHB-Deficient Sphingan (Diutan)
US6663911B2 (en) 2001-02-01 2003-12-16 C. P. Kelco U.S., Inc. Methods of making sterilized milk compositions comprising native gellan gum
WO2004002240A2 (en) 2002-06-26 2004-01-08 Danisco A/S Use of hydrocolloids as prebiotic food ingredients and method of producing the same
US8685943B2 (en) * 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
CN102077854A (zh) * 2003-10-16 2011-06-01 泰克康姆集团公司 具有降低的血糖应答的可消化性降低的碳水化合物食物
WO2005117607A2 (en) 2004-05-26 2005-12-15 Cp Kelco U.S., Inc. Calcium stable high acyl gellan gum for enhanced colloidal stability in beverages
US8530447B2 (en) * 2005-10-24 2013-09-10 Nestec S.A. Dietary fiber formulation and method of administration
US20070196439A1 (en) * 2006-02-13 2007-08-23 Catani Steven J Lactose-reduced dairy compositions and related methods
US20080008814A1 (en) 2006-06-22 2008-01-10 Philip Henry Jackson Acidified Protein Beverages Containing Suspended Particulates and Methods of Making Same
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
PL2589302T3 (pl) * 2007-12-21 2017-05-31 N.V. Nutricia Zastosowanie sfingomieliny i niestrawnych węglowodanów do poprawiania mikroflory jelitowej
CN101585886B (zh) * 2009-06-03 2012-10-03 浙江帝斯曼中肯生物科技有限公司 一种高酰基结冷胶的后提取方法
US8313789B2 (en) 2009-06-10 2012-11-20 The United States Of America, As Represented By The Secretary Of Agriculture Methods of promoting the growth of beneficial bacteria in the gut
JP6006117B2 (ja) * 2009-11-12 2016-10-12 ネステク ソシエテ アノニム 腸内微生物叢バランス及び健康を促進するための栄養組成物
US20160263170A1 (en) * 2014-01-30 2016-09-15 NatGood IP, LLC Natural sweetener
WO2015192247A1 (en) * 2014-06-21 2015-12-23 The Royal Institution For The Advancement Of Learning/Mcgill University Enzymatic production of prebiotic oligosaccharides from potato pulp
BR112017011078B1 (pt) 2014-11-28 2021-05-11 Anagenix Ip Limited usos de uma composição preparada a partir de kiwi ouro seco
MD992Z (ro) * 2015-04-08 2016-08-31 Общественное Учреждение "Научно-Практический Институт Садоводства И Пищевых Технологий" Procedeu de obţinere a umpluturii pentru produse de panificaţie şi cofetărie cu termostabilitate prestabilită
US10638783B2 (en) 2015-04-13 2020-05-05 Cp Kelco U.S., Inc. Gellan gum products and methods of manufacture and use thereof
EP3334437A1 (en) * 2015-08-25 2018-06-20 Kaleido Biosciences, Inc. Glycan compositions and uses thereof
AU2015410635B2 (en) * 2015-09-29 2021-08-19 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
US11697692B2 (en) * 2017-11-03 2023-07-11 Dsm Nutritional Products, Llc Methods of producing glycan polymers
CN109294950B (zh) * 2018-10-11 2021-03-30 浙江理工大学 高活性结冷胶寡糖产生菌及其应用

Similar Documents

Publication Publication Date Title
Stockbruegger Bacterial overgrowth as a consequence of reduced gastric acidity
CN1109543C (zh) 包括二十碳五烯酸和/或十八碳四烯酸的药物制剂
JP4491348B2 (ja) プレバイオティック組成物
CA2604778C (fr) Composition anti-inflammatoire et/ou analgesique de l'intestin comprenant des maltodextrines branchees
Steinberg et al. Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm
Kim Short-chain fatty acids in ulcerative colitis
CN101043904A (zh) 含有不可消化寡糖的营养组合物
CN114712298A (zh) 一种促进口腔健康的益生元和后生元组合物及其应用
JP2004509922A (ja) ヒト及び脊椎動物における全身感染の食物繊維による抑制
CN110520119A (zh) 口服微生物群促进组合物及其使用方法
EA002134B1 (ru) Применение комплекса гиалуроната цинка для лечения пептической язвы
JP5457675B2 (ja) アトピー性皮膚炎の治療薬又は予防薬
US11896571B2 (en) Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs
JPWO2020150389A5 (es)
CN116999344A (zh) 一种生物酶组合物及其制备方法及制得的牙膏
CA2000277A1 (en) Treatment of periodontal disease
JPS62103022A (ja) 化学療法剤の副作用低減化剤
EP2515910B1 (fr) Utilisation de polysaccharides dans le traitement du stress et de l'anxiété
JP2009143836A (ja) 歯周病の予防又は治療用の食品組成物、口腔組成物
AU2003247042A1 (en) Gastrointestinal compositions comprising gaba derivatives
WO2024024149A1 (ja) 脂肪性肝疾患抑制剤
JP2568833B2 (ja) う蝕予防剤
JP5035787B2 (ja) α−1、4結合型N−アセチルグルコサミン含有O−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JPS63119416A (ja) 抗齲蝕剤
WO2004006902A1 (en) Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib